These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10440409)

  • 41. Daclizumab to prevent acute rejection in renal transplantation.
    Abramowicz D
    N Engl J Med; 1998 Jun; 338(23):1700-1. PubMed ID: 9616069
    [No Abstract]   [Full Text] [Related]  

  • 42. IL-2 antibody induction and the outcome of pediatric renal transplants.
    Garcia CD; Barros VR; Schneider L; Alves MD; Silveira CG; Garcia VD
    Transplant Proc; 2002 Nov; 34(7):2914-5. PubMed ID: 12431655
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?
    Van Gelder T; Warlé M; Ter Meulen RG
    Drugs; 2004; 64(16):1737-41. PubMed ID: 15301558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
    Waldmann TA
    J Clin Immunol; 2007 Jan; 27(1):1-18. PubMed ID: 17216565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: a single-center experience.
    Soltero L; Carbajal H; Sarkissian N; Khan AJ; Brennan S; Gonzalez JM; Truong LD; Suki WN
    Transplantation; 2004 Nov; 78(10):1560-3. PubMed ID: 15599323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine-sparing effects of daclizumab in renal allograft recipients.
    Ingle GR; Moudgil A; Vo A; Jordan SC
    Am J Health Syst Pharm; 2005 Feb; 62(4):391-6. PubMed ID: 15745891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
    Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S
    Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis.
    Sun ZJ; Du X; Su LL; Zhang XD; Wang W
    Transplant Proc; 2015 Oct; 47(8):2439-45. PubMed ID: 26518947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New immunosuppressive agents in pediatric renal transplantation.
    Ettenger RB
    Transplant Proc; 1998 Aug; 30(5):1956-8. PubMed ID: 9723350
    [No Abstract]   [Full Text] [Related]  

  • 51. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F; Ramos E; Brattstrom C; Cho S; Ekberg H; Grinyo J; Johnson R; Kuypers D; Stuart F; Khanna A; Navarro M; Nashan B
    Transplantation; 2001 May; 71(9):1282-7. PubMed ID: 11397963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation.
    Koch M; Niemeyer G; Patel I; Light S; Nashan B
    Transplantation; 2002 May; 73(10):1640-6. PubMed ID: 12042653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti interleukin-2 receptor alpha antibodies (daclizumab) application for the treatment of kidney recipients].
    Izvolskaja N; Rainiene T; Dainys B
    Medicina (Kaunas); 2003; 39 Suppl 1():166-70. PubMed ID: 12761441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
    Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
    Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation.
    Aktas S; Colak T; Baskin E; Sevmis S; Ozdemir H; Moray G; Karakayali H; Haberal M
    Transplant Proc; 2011 Mar; 43(2):453-7. PubMed ID: 21440732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function.
    González E; Gutiérrez E; Hernández Y; Roselló G; Gutiérrez MJ; Martínez EG; Manzanera MJ; García JA; Praga M; Morales JM; Andrés A
    Transplant Proc; 2005 Nov; 37(9):3736-7. PubMed ID: 16386522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM; Li LS; Cheng Z; Cheng DR; Sun QQ; Chen JS; Sha GZ; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation.
    Joyal D; Cantarovich M; Cecere R; Giannetti N
    Clin Transplant; 2004 Oct; 18(5):493-6. PubMed ID: 15344949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
    Hirose R; Roberts JP; Quan D; Osorio RW; Freise C; Ascher NL; Stock PG
    Transplantation; 2000 Jan; 69(2):307-11. PubMed ID: 10670644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.